 |
|
Frequency of Facial Basal Cell Carcinoma Does Not Correlate With Site-Specific UV Exposure
Marc Heckmann, MD;
Frank Zogelmeier, MD;
Birger Konz, MD
Arch Dermatol. 2002;138:1494-1497.
ABSTRACT
| |
Background Basal cell carcinoma (BCC) is the most common type of skin cancer in whites. Long-term exposure to UV radiation is considered a major risk factor. We decided to investigate whether maximally exposed areas of the body are also the most frequent sites where BCCs develop.
Design Retrospective analysis of distribution and histopathologic features of 3065 facial BCCs.
Setting University hospital.
Patients Patients with primary or recurrent BCC of the face.
Intervention Exact topographic documentation followed by removal of BCC with Mohs prcedure and analysis of tumor extension.
Main Outcome Measure To test the hypothesis that site-specific UV exposure correlates with site-specific BCC frequency.
Results The most frequent sites of BCC were the nose (n = 1373), orbital area (n = 386), and ears (n = 269). Subdivision of these anatomical units showed that most nasal BCCs are located at the base of the nose (n = 851), while the apex (n = 292) and the dorsum of the nose (n = 230) were less frequent sites despite their prominent sun exposure. The shaded retroauricular fold (n = 99) and the sun-exposed preauricular crest (n = 105) were similar in frequency of BCCs; fewer BCCs were located on the helix of the ears (n = 65). Finally, almost 10 times more BCCs were found in the medial quadrant of the orbit (n = 225) than in the lateral quadrant (n=24). No correlation between prominent UV-exposed facial contours and particular histologic features, such as solid, morpheaform, or adenoid-cystic, could be established.
Conclusions Site-specific cumulative UV exposure alone is a poor predictor of frequency or histologic features of BCC. Additional site-specific textural qualities of facial skin may be considered as potential cofactors for the development of BCC.
INTRODUCTION
BASAL CELL carcinoma (BCC) is the most common skin cancer in whites, with a steadily increasing incidence.1 Ultraviolet radiation is considered as the single most important risk factor for BCC, because the tumor occurs most frequently on sun-exposed areas of the body, with approximately 4 of 5 BCCs occurring on the face.1-2 Furthermore, BCC has a higher incidence in patients who have a fair complexion, reflecting an inadequate biological ability for UV protection by tanning,3-5 and patients exposed to excessive UV radiation in the course of phototherapy have a higher risk of developing BCC.6
However, a simple correlation such as "the more UV radiation, the more skin cancer" does not explain adequately the pattern of occurrence of BCC: Why is the tumor so rarely found in certain extrafacial localizations, eg, the dorsal aspect of the hand despite considerable UV exposure,7 and why is the tumor conspicuously frequent in certain facial regions, such as the orbit, which are less exposed to UV radiation than the buccal or zygomatic regions? Unfortunately, most authors reporting larger series of BCC2, 8-10 are referring to rather crude anatomical divisions (eg, forehead, nose, and ears), without acknowledging that UV exposure is critically dependent on anatomical details of the elaborate facial contour.11
Another enigma of BCC is its way of spreading, which correlates in part to particular histologic features12: morpheaform BCC has been reported to show more widespread and irregular tumor formation than solid or adenoid-cystic BCC.13 Superficial BCC, which occurs more frequently on the trunk than on the face, is the least agressive type. Therefore, we decided to investigate whether anatomical prominences with peak UV exposure have correlating peak frequencies and/or distinct histologic features of BCC.
This report summarizes data derived from 3065 facial BCCs in 2785 patients, giving a comprehensive account of localization with respect to particular facial areas, histopathologic differentiation, and correlation to UV exposure.
METHODS
The study material included clinical reports of patients who were admitted to the Department of Dermatology, Ludwig Maximilians University, Munich, Germany, for treatment of BCC between the years 1979 and 1994 and who fulfilled the following criteria: the BCC was located on the face and the clinical diagnosis was confirmed by the findings of microscopic examination of a skin biopsy specimen. Based on the predominant histopathologic appearance, BCCs were categorized as either solid, morpheaform, or adenoid-cystic. Pigmented BCCs were categorized according to their predominant histologic features.
The exact anatomical localization and extension of BCCs were documented on a uniform schematic drawing in a 1:1 scale. The periocular area was further subdivided into 4 equal segments (ie, the lateral, medial, upper, and lower quadrants [Figure 1A]). Likewise, the nose was divided into 4 segments by taking a lateral view with 2 segments on each side: the basal segment of the nose bordering to the nasolabial fold extending midway up the side of the nose, and the upper segment of the nose extending from midway to the back of the nose, including the apex (Figure 1A).
|
|
|
|
Figure 1. A, Delineation of anatomical subregions of the orbital and nasal regions: 1 indicates apex of the nose; 2, dorsum of the nose; 3, basal segment, right side; 4, medial orbital segment; 5, lower orbital segment; 6, upper orbital segment; and 7, lateral orbital segment. Note: For the nose, the upper segment was defined as the apex and the dorsum (1 and 2), while the basal segment consisted of the basal aspect and the alae nasi (3) on both sides of the nose. B, Frequencies of basal cell carcinomas (BCCs) within topographic regions of the face.
|
|
|
Data collection and processing were carried out using commercially available computer software (Excel; Microsoft Worldwide, and SPSS; SPSS Inc, Chicago, Ill). The  2 test was used to calculate the level of significance for differences of BCC frequencies within comparable segments.
RESULTS
A total of 3065 BCCs were studied in 2785 patients, 297 (11%) of whom had more than 1 facial BCC at the time of diagnosis. Men were slightly more prevalent (53%) than women. The youngest patient was 20 years old; the oldest, 101. The mean ± SD age of the patients at the time of diagnosis was 63.2 ± 12.9 years. The incidence of BCC increased steadily up to the eighth decade of life (Figure 2). Only 16 patients (0.6%) were younger than 30 years, and 496 (17.8 %) were younger than 50 years. There was no difference between men and women regarding age at the time of diagnosis of BCC.
|
|
|
|
Figure 2. Age of patients at the time of diagnosis of basal cell carcinoma.
|
|
|
The localizations of facial BCCs are shown in Figure 1B. The nose, as the most prominent facial anatomical structure, was also the most frequent site of BCC (n = 1373, or 44.8%). Of the 1373 nasal BCCs, however, 851 (62.0%) occurred on the base of the nose, while only 292 (21.3%) occurred on the apex and 230 (16.8%) occurred on the dorsum of the nose (Figure 1A). Assuming that the surface areas of the upper (apex and dorsum) and lower (alae and base) segments of the nose were comparable, the difference was significant at P<.05.
The orbital region harbored 12.6% (386/3065) of all facial BCCs, which were unevenly distributed, with 58.3% (225/386) in the medial quadrant and only 6.2% (24/386) in the lateral quadrant (P<.001) (Figure 3A). Of 269 auricular BCCs, 105 (39.0%) were located at the preauricular crest, 99 (36.8%) in the retroauricular fold, and 65 (24.2%) on the helix of the ear (Figure 3B). When the putative effects of hairstyles that cover the ears were taken into account, there was no difference in frequencies of auricular and retroauricular BCCs in men and women. The least affected facial prominence was the chin (47/3065, or 1.5%). For each region specified in Figure 1B, there was no significant difference (P>.05) when patients aged 63 years or older (n = 1804) were compared with younger patients (n = 1261).
|
|
|
|
Figure 3. Percentages of basal cell carcinomas within topographic subregions of the orbital (A [n = 386]) and auricular (B [n = 269]) regions. For details of subregions, see Figure 1A.
|
|
|
The predominant histopathologic subtypes in descending order of frequency were solid (1514/3065, or 49.4%), morpheaform (1149/3065, 37.5%), and adenoid-cystic (402/3065, or13.1%). Of the 1149 morpheaform tumors, 928 displayed exclusively morpheaform features, while the remaining 221 were composed of solid tumor islands mixed with morpheaform features. The distribution of these histopathologic types in the aforementioned regions is shown in Figure 4. In descending order, the buccal, temporal, perioral, and frontal regions displayed a relatively high percentage of morpheaform BCCs, exceeding the percentage of solid BCCs. Comparison of histopathologic types in both sexes revealed that solid BCCs occurred 1.2 times more frequently in men than in women, while morpheaform BCCs were 1.3 times more frequent in women (P<.001).
|
|
|
|
Figure 4. Histologic subtypes of basal cell carcinomas within topographic regions.
|
|
|
COMMENT
Chronic UV exposure has been postulated to be a causative factor for the development of skin cancer. The capacity of DNA repair after UV irradiation is lower in patients with BCC than in controls.14 A number of UV-induced phenomena have been identified as putative mechanisms of BCC development. Clonal expansion of mutant p53 is frequently overexpressed in and around BCCs on sun-exposed skin.15-16 Mutations of the oncogene H-ras occur with increased frequencies in BCCs,17 while the expression of the oncogene c-fos is reduced.18 Levels of interleukin 4 and interleukin 10 are elevated by UV irradiation, reducing immunologic tumor surveillance.19 Interstitial collagenase is UV inducible,20-21 fostering local tumor invasion.22 If these mechanisms, however, which are operating in a UV dose–dependent fashion, are the driving force of tumor development, one would expect the highest frequency of BCCs in those sites of the face that are receiving the most exposure to UV radiation.
The doses of UV radiation received in various parts of the face have been measured with UV-sensitive halogen-free radicals on the surface of mannequin heads with respect to topographic anatomy.11 Accordingly, the apex of the nose and the helical part of the ears were the most exposed areas, receiving twice as much UV radiation as the buccal and zygomatic regions and up to 10 times more than the orbital region. We found that the orbital region was more frequently affected than the buccal and zygomatic regions, indicating a mismatch of BCC frequencies with UV exposure. These areas may differ in size and are therefore difficult to compare numerically. However, comparing the equally sized lateral and medial quadrants of the orbit, we found an even more conspicuous misbalance of BCC frequency, which is unexplainable by UV exposure. The hypothesis that UV radiation may be intensified unproportionately by glasses worn to correct impaired vision in the elderly could not be confirmed by the respective UV measurements using such glasses.11 Another sign of a lack of correlation of UV exposure and BCC frequency is the inverse distribution of BCCs on less exposed basal segments of the nose and the retroauricular fold. Finally, BCC is a tumor of advanced age. Our findings of peak incidence within the eighth decade of life confirm the observations of a recent study.8 Consequently, the differences of cumulative UV exposure in various sites should be more pronounced over time. In our study, however, the age of the patients had no influence on the frequency pattern of BCCs.
Descriptively, those areas with high BCC frequency despite low UV exposure are characterized by a concave shape, reduced skin tension, and the presence of marked skin folds. These features may reflect reduced dermal thickness and altered connective tissue arrangements. This may influence the expression of metalloproteases such as collagenases, which are responsible for tissue breakdown in the course of tumor expansion23 and which are overexposed in and around BCCs.22, 24 Furthermore, metalloproteases in BCCs and adjacent stromal cells are dependent on integrins.25 Several integrins that operate as cell matrix receptors were found to be reduced26 or even completely absent27 in BCCs.
In conclusion, the development of facial BCCs appears to be poorly correlated to the cumulative effects of UV radiation alone. Specific textural changes, such as reduced tension and dermal thickness, may putatively explain this mismatch and point toward disturbed cell matrix interactions as a cofactor for the development of BCCs.
AUTHOR INFORMATION
Accepted for publication May 16, 2002.
This research was supported by Ludwig-Maximilians University, Munich, Germany, and by grant GSF 07 UVB 59/2 from the Bundesministerium für Bildung, Forschung, Wissenschaft und Technologie (BMBF), Berlin, Germany.
Corresponding author: Marc Heckmann, MD, Department of Dermatology, Ludwig-Maximilians University, Frauenlobstrasse 9-11, 80337 München, Germany (e-mail: heckmann{at}derma.de).
From the Department of Dermatology, Ludwig-Maximilians University, Munich, Germany.
REFERENCES
| |
1. Marks R. An overview of skin cancers: incidence and causation. Cancer. 1995;75:607-612.
FULL TEXT
|
ISI
| PUBMED
2. Ashby MA, Smith J, Ainslie J, McEwan L. Treatment of nonmelanoma skin cancer at a large Australian center. Cancer. 1989;63:1863-1871.
FULL TEXT
|
ISI
| PUBMED
3. Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer, I: basal cell carcinoma. Arch Dermatol. 1995;131:157-163.
FREE FULL TEXT
4. Halder RM, Bridgeman-Shah S. Skin cancer in African Americans. Cancer. 1995;75:667-773.
FULL TEXT
|
ISI
| PUBMED
5. Abreo F, Sanusi ID. Basal cell carcinoma in North American blacks: clinical and histopathologic study of 26 patients. J Am Acad Dermatol. 1991;25(6 Pt 1):1005-1011.
6. Morison WL. Recent advances in phototherapy and photochemotherapy of skin disease. Dermatol Sci. 1990;1:141-147.
7. Bean DJ, Rees RS, O'Leary JP, Lynch JB. Carcinoma of the hand: a 20-year experience. South Med J. 1984;77:998-1000.
ISI
| PUBMED
8. Betti R, Inselvini E, Carducci M, Crosti C. Age and site prevalence of histologic subtypes of basal cell carcinomas. Int J Dermatol. 1995;34:174-176.
ISI
| PUBMED
9. Breuninger H, Dietz K. Prediction of subclinical tumor infiltration in basal cell carcinoma. J Dermatol Surg Oncol. 1991;17:574-578.
ISI
| PUBMED
10. Dubin N, Kopf AW. Multivariant risk score for recurrence of cutaneous basal cell carcinomas. Arch Dermatol. 1983;119:373-375.
FREE FULL TEXT
11. Urbach F. Geographic pathology of skin cancer. In: Biologic Effects of Ultraviolet Radiation (With Emphasis on Skin). Oxford, England: Pergamon Press; 1969:635-650.
12. Dellon AL, DeSilva S, Connolly M, Ross A. Prediction of recurrence in incompletely excised basal cell carcinoma. Plast Reconstr Surg. 1985;75:860-871.
ISI
| PUBMED
13. Dixon AY, Lee SH, McGregor DH. Histologic evolution of basal cell carcinoma recurrence. Am J Dermatopathol. 1991;13:241-247.
ISI
| PUBMED
14. Wei Q, Matanoski GM, Farmer ER, Hedayati MA, Grossman L. DNA repair capacity for ultraviolet light–induced damage is reduced in peripheral lymphocytes from patients with basal cell carcinoma. J lnvest Dermatol. 1995;104:933-936.
FULL TEXT
|
ISI
| PUBMED
15. Shea CR, McNutt NS, Volkenandt M, Lugo J, Prioleau PG, Albino AP. Overexpression of p53 protein in basal cell carcinomas of human skin. Am J Pathol. 1992;141:25-29.
ABSTRACT
16. Urano Y, Asano T, Yoshimoto K, et al. Frequent p53 accumulation in the chronically sun-exposed epidermis and clonal expansion of p53 mutant cells in the epidermis adjacent to basal cell carcinoma. J Invest Dermatol. 1995;104:928-932.
FULL TEXT
|
ISI
| PUBMED
17. Amstad PA, Cerutti PA. Ultraviolet-B-light–induced mutagenesis of C-H-ras codons 11 and 12 in human skin fibroblasts. Int J Cancer. 1995;63:136-139.
ISI
| PUBMED
18. Urabe A, Nakayama J, Taniguchi S, Kuroki R, Hori Y. Expression of the fos oncogene in basal cell carcinoma. J Dermatol Sci. 1994;8:50-53.
FULL TEXT
| PUBMED
19. Kim J, Modlin RL, Moy RL, et al. IL-10 production in cutaneous basal and squamous cell carcinomas: a mechanism for evading the local T cell immune response. J Immunol. 1995;155:2240-2247.
ABSTRACT
20. Scharffetter K, Wlaschek M, Hogg A, et al. UV-A irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res. 1991;283:506-511.
FULL TEXT
|
ISI
| PUBMED
21. Wlaschek M, Briviba K, Stricklin GP, Sies H, Scharffetter KK. Singlet oxygen may mediate the ultraviolet A–induced synthesis of interstitial collagenase. J Invest Dermatol. 1995;104:194-198.
FULL TEXT
|
ISI
| PUBMED
22. Goslen JB, Bauer EA. Basal cell carcinoma and collagenase. J Dermatol Surg Oncol. 1986;12:812-817.
ISI
| PUBMED
23. Karelina TV, Goldberg GI, Eisen AZ. Matrix metalloproteinases in blood vessel development in human fetal skin and in cutaneous tumors. J Invest Dermatol. 1995;105:411-417.
FULL TEXT
|
ISI
| PUBMED
24. Grigioni WF, D'Errico A, Fiorentino M, et al. Gelatinase A (MMP-2) and its mRNA detected in both neoplastic and stromal cells of tumors with different invasive and metastatic properties. Diagn Mol Pathol. 1994;3:163-169.
ISI
| PUBMED
25. Albelda SM. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest. 1993;68:4-17.
ISI
| PUBMED
26. Stamp GW, Pignatelli M. Distribution of beta 1, alpha 1, alpha 2 and alpha 3 integrin chains in basal cell carcinomas. J Pathol. 1991;163:307-313.
FULL TEXT
|
ISI
| PUBMED
27. Savoia P, Trusolino L, Pepino E, Cremona O, Marchisio PC. Expression and topography of integrins and basement membrane proteins in epidermal carcinomas: basal but not squamous cell carcinomas display loss of alpha 6 beta 4 and BM-600/nicein. J Invest Dermatol. 1993;101:352-358.
FULL TEXT
|
ISI
| PUBMED
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
'The Health of the Nation' - an unattainable skin cancer target predictably remains beyond reach
Cox
JRSM 2009;102:177-180.
FULL TEXT
Fill the Mind--and Exercise It, Too!
Ackerman
Arch Dermatol 2003;139:940-940.
FULL TEXT
|
